These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Bone metabolism in dyslipidemia and metabolic syndrome]. Yamaguchi T Clin Calcium; 2011 May; 21(5):677-82. PubMed ID: 21532116 [TBL] [Abstract][Full Text] [Related]
23. Genetic variation at the low-density lipoprotein receptor-related protein 5 (LRP5) locus modulates Wnt signaling and the relationship of physical activity with bone mineral density in men. Kiel DP; Ferrari SL; Cupples LA; Karasik D; Manen D; Imamovic A; Herbert AG; Dupuis J Bone; 2007 Mar; 40(3):587-96. PubMed ID: 17137849 [TBL] [Abstract][Full Text] [Related]
24. LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. He X; Semenov M; Tamai K; Zeng X Development; 2004 Apr; 131(8):1663-77. PubMed ID: 15084453 [TBL] [Abstract][Full Text] [Related]
25. PTH stimulates bone formation in mice deficient in Lrp5. Iwaniec UT; Wronski TJ; Liu J; Rivera MF; Arzaga RR; Hansen G; Brommage R J Bone Miner Res; 2007 Mar; 22(3):394-402. PubMed ID: 17147489 [TBL] [Abstract][Full Text] [Related]
30. Cross-talk between Wnt signaling pathways in human mesenchymal stem cells leads to functional antagonism during osteogenic differentiation. Baksh D; Boland GM; Tuan RS J Cell Biochem; 2007 Aug; 101(5):1109-24. PubMed ID: 17546602 [TBL] [Abstract][Full Text] [Related]
31. The holy grail of high bone mass. Bonewald L Nat Med; 2011 Jun; 17(6):657-8. PubMed ID: 21647140 [No Abstract] [Full Text] [Related]
32. Expression of LDL receptor-related protein 5 (LRP5) as a novel marker for disease progression in high-grade osteosarcoma. Hoang BH; Kubo T; Healey JH; Sowers R; Mazza B; Yang R; Huvos AG; Meyers PA; Gorlick R Int J Cancer; 2004 Mar; 109(1):106-11. PubMed ID: 14735475 [TBL] [Abstract][Full Text] [Related]
33. Mesd encodes an LRP5/6 chaperone essential for specification of mouse embryonic polarity. Hsieh JC; Lee L; Zhang L; Wefer S; Brown K; DeRossi C; Wines ME; Rosenquist T; Holdener BC Cell; 2003 Feb; 112(3):355-67. PubMed ID: 12581525 [TBL] [Abstract][Full Text] [Related]
34. [Cytokines in bone diseases. Wnt signal and excessive bone formation]. Hosoi T Clin Calcium; 2010 Oct; 20(10):1526-31. PubMed ID: 20890035 [TBL] [Abstract][Full Text] [Related]
35. 1,25-Dihydroxyvitamin D3 regulates the expression of low-density lipoprotein receptor-related protein 5 via deoxyribonucleic acid sequence elements located downstream of the start site of transcription. Fretz JA; Zella LA; Kim S; Shevde NK; Pike JW Mol Endocrinol; 2006 Sep; 20(9):2215-30. PubMed ID: 16613987 [TBL] [Abstract][Full Text] [Related]
36. Role of the intracellular domains of LRP5 and LRP6 in activating the Wnt canonical pathway. Mi K; Johnson GV J Cell Biochem; 2005 May; 95(2):328-38. PubMed ID: 15778991 [TBL] [Abstract][Full Text] [Related]
37. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. Rawadi G; Vayssière B; Dunn F; Baron R; Roman-Roman S J Bone Miner Res; 2003 Oct; 18(10):1842-53. PubMed ID: 14584895 [TBL] [Abstract][Full Text] [Related]
38. Gender specific LRP5 influences on trabecular bone structure and strength. Dubrow SA; Hruby PM; Akhter MP J Musculoskelet Neuronal Interact; 2007; 7(2):166-73. PubMed ID: 17627087 [TBL] [Abstract][Full Text] [Related]
39. The low-density lipoprotein class A module of the relaxin receptor (leucine-rich repeat containing G-protein coupled receptor 7): its role in signaling and trafficking to the cell membrane. Kern A; Agoulnik AI; Bryant-Greenwood GD Endocrinology; 2007 Mar; 148(3):1181-94. PubMed ID: 17158203 [TBL] [Abstract][Full Text] [Related]
40. LRP1-dependent pepsin clearance induced by 2'-hydroxycinnamaldehyde attenuates breast cancer cell invasion. Kang HS; Kim J; Lee HJ; Kwon BM; Lee DK; Hong SH Int J Biochem Cell Biol; 2014 Aug; 53():15-23. PubMed ID: 24796846 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]